GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Enwei Pharmaceutical Co Ltd (SZSE:301331) » Definitions » Other Income (Expense)

Enwei Pharmaceutical Co (SZSE:301331) Other Income (Expense) : ¥2.5 Mil (TTM As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Enwei Pharmaceutical Co Other Income (Expense)?

Enwei Pharmaceutical Co's other income expense for the Enwei Pharmaceutical Co's pretax income for the three months ended in Mar. 2024 was ¥0.1 Mil. Its other income expense for the trailing twelve months (TTM) ended in Mar. 2024 was ¥2.5 Mil.


Enwei Pharmaceutical Co Other Income (Expense) Historical Data

The historical data trend for Enwei Pharmaceutical Co's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enwei Pharmaceutical Co Other Income (Expense) Chart

Enwei Pharmaceutical Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Income (Expense)
Get a 7-Day Free Trial 6.01 7.30 1.66 -1.09 2.71

Enwei Pharmaceutical Co Quarterly Data
Dec17 Dec18 Dec19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.31 0.46 0.83 1.10 0.06

Enwei Pharmaceutical Co Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥2.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Enwei Pharmaceutical Co  (SZSE:301331) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.


Enwei Pharmaceutical Co (SZSE:301331) Business Description

Traded in Other Exchanges
N/A
Address
Chuangye Avenue, Enwei Building, Economic Development Zone, Aba District, Tibet Autonomous Region, Changdu, CHN, 854000
Enwei Pharmaceutical Co Ltd is engaged in the research and development, production and sales of proprietary Chinese medicines and chemical medicines.

Enwei Pharmaceutical Co (SZSE:301331) Headlines

No Headlines